Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MR-guided Tumour Boost With Stereotactic Body Radiotherapy in Prostate Cancer

NCT05364229 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT05364229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05364229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MR-guided Tumour Boost With Stereotactic Body Radiotherapy in Prostate Cancer
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 6, 2023
Completion date
June 30, 2030
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer